Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes
- PMID: 1449532
- DOI: 10.1016/0006-2952(92)90068-t
Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes
Abstract
Kinetics of the 2- and 4-hydroxylations of estradiol (E2) by human liver microsomal samples were studied to determine the major P450 isoform involved in these endogenous reactions. Thirty human liver microsomal samples were analysed. Metabolism of 25 microM [14C]E2 produced 2-hydroxy and 4-hydroxy derivatives with a ratio of 3.2 +/- 1.5 and a great inter-individual variation. Kinetic analysis of the 2- and 4-hydroxylations of E2 exhibited a curvilinear double reciprocal plot with an apparent Km of 15 microM. Further experiments demonstrated that alpha-naphthoflavone, testosterone and progesterone increased the 2-hydroxylation activity, suggesting the involvement of a substrate activation mechanism. These two hydroxylations of E2 were shown to be catalysed by cytochrome P450 with an apparent dissociation constant Ks of 0.8 microM. These 2- and 4-hydroxylations inter-correlated significantly (r = 0.93; N = 30). The 2-hydroxylation of E2 correlated with four monooxygenase activities known to be supported by P450 3A4/3A5, namely nifedipine oxidation (r = 0.78; N = 29); erythromycin N-demethylation (r = 0.69; N = 27), testosterone 6 beta-hydroxylation (r = 0.66; N = 25) and tamoxifen N-demethylation (r = 0.64; N = 29). On the other hand, E2-hydroxylations did not correlate with activities supported by P450 1A2 and P450 2E1. Furthermore, drugs as cyclosporin, diltiazem, triacetyl-oleandomycin and 17 alpha-ethynylestradiol inhibited more than 90% of the E2-hydroxylations at concentrations < 250 microM, while weak inhibition was shown with 500 microM cimetidine and no significant inhibition with caffeine, phenacetin and omeprazole. Finally, 2- and 4-hydroxylations of E2 correlated significantly with the content of P450 3A4/3A5 immunodetected by a monoclonal antibody anti-human P450-nifedipine (r = 0.84; N = 28). E2-hydroxylation activities were inhibited by more than 80% with polyclonal anti-human anti-P450-nifedipine. Preincubation of human liver microsomes with 100 microM gestodene (a suicide substrate of P450 3A4) inactivated this P450 isoform and accordingly allowed evaluation of the contribution of other P450 isoforms to the E2 metabolism to about 21% (+/- 17%, N = 29). All these results taken together suggest that P450 3A4/3A5 are the major forms involved in the formation of catecholestrogens in the human liver microsomes.
Similar articles
-
Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.Biochem Pharmacol. 1994 May 18;47(10):1883-95. doi: 10.1016/0006-2952(94)90319-0. Biochem Pharmacol. 1994. PMID: 8204106
-
Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.Chem Res Toxicol. 1998 Jun;11(6):659-65. doi: 10.1021/tx970217f. Chem Res Toxicol. 1998. PMID: 9625734
-
Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.Biochem Pharmacol. 1994 May 18;47(10):1767-76. doi: 10.1016/0006-2952(94)90304-2. Biochem Pharmacol. 1994. PMID: 8204093
-
Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance.Anesthesiology. 1992 Sep;77(3):467-74. doi: 10.1097/00000542-199209000-00011. Anesthesiology. 1992. PMID: 1519785 Review.
-
Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes.Biochem Pharmacol. 1999 Mar 1;57(5):465-80. doi: 10.1016/s0006-2952(98)00268-8. Biochem Pharmacol. 1999. PMID: 9952310 Review.
Cited by
-
Estrogens and the risk of breast cancer: A narrative review of literature.Heliyon. 2023 Sep 17;9(9):e20224. doi: 10.1016/j.heliyon.2023.e20224. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809638 Free PMC article. Review.
-
Gender effects in pharmacokinetics and pharmacodynamics.Drugs. 1995 Aug;50(2):222-39. doi: 10.2165/00003495-199550020-00003. Drugs. 1995. PMID: 8521756 Review.
-
Urinary 2/16 estrogen metabolite ratio levels in healthy women: a review of the literature.Mutat Res. 2010 Oct;705(2):154-162. doi: 10.1016/j.mrrev.2010.06.004. Epub 2010 Jul 1. Mutat Res. 2010. PMID: 20601100 Free PMC article. Review.
-
Ancestral Sequence Reconstruction of a Cytochrome P450 Family Involved in Chemical Defense Reveals the Functional Evolution of a Promiscuous, Xenobiotic-Metabolizing Enzyme in Vertebrates.Mol Biol Evol. 2022 Jun 2;39(6):msac116. doi: 10.1093/molbev/msac116. Mol Biol Evol. 2022. PMID: 35639613 Free PMC article.
-
4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis.Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9220-4. doi: 10.1073/pnas.92.20.9220. Proc Natl Acad Sci U S A. 1995. PMID: 7568105 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources